VIR BIOTECHNOLOGY, I

VIR
Delayed Quote. Delayed  - 04/09 04:00:01 pm
43.13USD -3.77%

Vir Biotechnology : , GlaxoSmithKline Halts Enrollment in Phase 3 Trial of Experimental COVID-19 Drug

03/03/2021 | 10:57am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover